Formation Bio acquires and in-licenses promising drug assets, advancing them through critical development milestones (Phase II and beyond), and then ...

New appointments of Drs. Philip C. Amrein and Alex Kentsis Validate Lead Galinpepimut-S and SLS009 Programs as Company Approaches Key Inflection Points This Year ...

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of ...

Pharmacokinetics: The pharmacokinetic profile of DF-003 was largely dose proportional and the data support additional clinical trials as a once-daily, orally administered drug.

Rakovina Therapeutics Inc., a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, announced a strategic financing of ...

“The Kymera team continues to advance our first-in-class pipeline ... Therapeutics. “We are making tremendous progress across our programs and approaching key near term inflection points.

Takeda spotlighted three late-stage readouts as a potential "inflection point" for the company ... bispecifics bagged in Maverick buyout amid pipeline clearout Takeda has terminated two T-cell ...

Rusfertide, a treatment for chronic blood disorder polycythemia vera that Takeda bought from Protagonist Therapeutics ... the three make an “inflection point” for the company, said Chief ...

A better entry point remains likely from here ... The current other contender in the early pipeline for JANX is JANX008, a TRACTr molecule targeting the receptor tyrosine kinase EGFR.

“Apriori has reached an inflection point as we transition from building out our platform to accelerating the development of our pipeline ... partnered Omega Therapeutics struck a restructuring ...

Feb. 13, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq ... most prevalent brain diseases with multiple near-term clinical inflection points. We have an industry leading pipeline and the ...

Inflection points signal key changes in business trajectory caused by changes like leadership or tech innovation. Anticipating inflection points can offer lucrative investment returns. Nvidia's ...